Physician profile
Soni Chousleb
NPI 1851552988
$38,360.84
in general payments reported to CMS, 2019-2025
12 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $23.73 · 2021: $472 · 2022: $12K · 2023: $7,487 · 2024: $18K · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $4,094 · Travel and Lodging: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Food and Beverage | $4,094.21 |
| Travel and Lodging | $1,353.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,297.85 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $1,548.93 | 2019-2023 | Phasix Mesh |
| Conmed Corporation | $1,381.64 | 2021-2025 | Airseal |
| W. L. Gore & Associates, INC. | $372.72 | 2021-2023 | Gore Enform Preperitoneal Biomaterial |
| Boston Scientific Corporation | $195.96 | 2022-2024 | Spyglass Discover, Exalt Model D |
| Stryker Corporation | $131.82 | 2021 | |
| Solventum Corporation | $120.46 | 2024 | V.A.C. Veraflo, Prevena |
| Ethicon US, LLC | $106.84 | 2024 | Megadyne |
| Becton, Dickinson and Company | $87.90 | 2023 | Phasix Mesh |
| Smith+Nephew, INC. | $59.12 | 2022-2023 | Grafix Pl, Oasis |
| Medtronic, INC. | $33.87 | 2022 | |
| Allergan, INC. | $23.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soni Chousleb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.